Synbindin in extracellular signal-regulated protein kinase spatial regulation and gastric cancer aggressiveness

Journal of the National Cancer Institute

Volumn 105, Issue 22, 2013, Pages 1738-1749

  Kong, Xuan ^a,b   Qian, Jin ^a,b   Chen, Li Sha ^a,b   Wang, Ying Chao ^a,b   Wang, Ji Lin ^a,b   Chen, Haoyan ^a,b   Weng, Yu Rong ^a,b   Zhao, Shu Liang ^a,b   Hong, Jie ^a,b   Chen, Ying Xuan ^a,b   Zou, Weiping ^c   Xu, Jie ^a,b   Fang, Jing Yuan ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b BEIJING HOSPITAL   (China)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PROTEIN; SYNBINDIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CANCER CELL CULTURE; CANCER GROWTH; CANCER SIZE; CANCER SURVIVAL; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; ENZYME REGULATION; FLUORESCENCE RESONANCE ENERGY TRANSFER; G2 PHASE CELL CYCLE CHECKPOINT; GOLGI COMPLEX; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; LYMPH NODE METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; STOMACH CANCER; STOMACH MUCOSA; TRANSACTIVATION; TUMOR INVASION;

ANIMALS; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; FLOW CYTOMETRY; FLUORESCENCE RESONANCE ENERGY TRANSFER; FLUORESCENT ANTIBODY TECHNIQUE; GASTRIC MUCOSA; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GOLGI APPARATUS; HETEROGRAFTS; HUMANS; KAPLAN-MEIER ESTIMATE; LUCIFERASES; LUMINESCENT AGENTS; MAP KINASE KINASE 1; MAP KINASE SIGNALING SYSTEM; MICE; MICE, NUDE; MITOGEN-ACTIVATED PROTEIN KINASE 1; NERVE TISSUE PROTEINS; NF-KAPPA B; ODDS RATIO; PHOSPHORYLATION; PROTEIN ARRAY ANALYSIS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION; VESICULAR TRANSPORT PROTEINS;

EID: 84890459245     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djt271     Document Type: Article

References (31)

1. Ueda T, Volinia S, Okumura H, et al. Relation between microRNA expression and progression and prognosis of gastric cancer: A microRNA expression analysis. Lancet Oncol. 2010;11(2):136-146.
2. Barrowman J, Bhandari D, Reinisch K, et al. TRAPP complexes in membrane traffic: convergence through a common Rab. Nat Rev Mol Cell Biol. 2010;11(11):759-763.
3. Cai Y, Chin HF, Lazarova D, et al. The structural basis for activation of the Rab Ypt1p by the TRAPP membrane-Tethering complexes. Cell. 2008;133(7):1202-1213.
4. Kim YG, Raunser S, Munger C, et al. The architecture of the multisubunit TRAPP I complex suggests a model for vesicle tethering. Cell. 2006;127(4):817-830.
5. Yu S, Liang Y. A trapper keeper for TRAPP, its structures and functions. Cell Mol Life Sci. 2012; doi:10.1007/s00018-012-1024-3.
6. Liu X, Wang Y, Zhu H, et al. Interaction of Sedlin with PAM14. J Cell Biochem. 2010;109(6):1129-1133.
7. Jeyabalan J, Nesbit MA, Galvanovskis J, et al. SEDLIN forms homodimers: characterisation of SEDLIN mutations and their interactions with transcription factors MBP1, PITX1 and SF1. PLoS One. 2010;5(5):e10646.
8. Fan L, Yu W, Zhu X. Interaction of sedlin with chloride intracellular channel proteins. FEBS Lett. 2003;540(1-3):77-80.
9. Hu WH, Pendergast JS, Mo XM, et al. NIBP, a novel NIK and IKK(beta)-binding protein that enhances NF-(kappa)B activation. J Biol Chem. 2005;280(32):29233-29241.
10. Gaborit N, Larbouret C, Vallaghe J, et al. Time-resolved fluorescence resonance energy transfer (TR-FRET) to analyze the disruption of EGFR/HER2 dimers: A new method to evaluate the efficiency of targeted therapy using monoclonal antibodies. J Biol Chem. 2011;286(13):11337-11345.
11. Sun Y, Day RN, Periasamy A. Investigating protein-protein interactions in living cells using fluorescence lifetime imaging microscopy. Nat Protoc. 2011;6(9):1324-1340.
12. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966;50(3):163-170.
13. Hoppeler-Lebel A, Celati C, Bellett G, et al. Centrosomal CAP350 protein stabilises microtubules associated with the Golgi complex. J Cell Sci. 2007;120(Pt 18):3299-3308.
14. Ethell IM, Hagihara K, Miura Y, et al. Synbindin, a novel syndecan-2-binding protein in neuronal dendritic spines. J Cell Biol. 2000;151(1):53-68.
15. Fan S, Feng Y, Wei Z, et al. Solution structure of synbindin atypical PDZ domain and interaction with syndecan-2. Protein Pept Lett. 2009;16(2):189-195.
16. Kaganman I. FRETting for a more detailed interactome. Nat Methods. 2007;4(2):112-113.
17. Maurel D, Comps-Agrar L, Brock C, et al. Cell-surface protein-protein interaction analysis with time-resolved FRET and snap-Tag technologies: Application to GPCR oligomerization. Nat Methods. 2008;5(6):561-567.
18. Guegan JP, Fremin C, Baffet G. The MAPK MEK1/2-ERK1/2 pathway and its implication in hepatocyte cell cycle control. Int J Hepatol. 2012;2012:328372.
19. Chen YJ, Tsai RK, Wu WC, et al. Enhanced PKCdelta and ERK signaling mediate cell migration of retinal pigment epithelial cells synergistically induced by HGF and EGF. PLoS One. 2012;7(9):e44937.
20. Khokhlatchev AV, Canagarajah B, Wilsbacher J, et al. Phosphorylation of the MAP kinase ERK2 promotes its homodimerization and nuclear translocation. Cell. 1998;93(4):605-615.
21. Kuraishy A, Karin M, Grivennikov SI. Tumor promotion via injury-And death-induced inflammation. Immunity. 2011;35(4):467-477.
22. Karin M, Greten FR. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol. 2005;5(10):749-759.
23. Messeguer X, Escudero R, Farre D, et al. PROMO: detection of known transcription regulatory elements using species-Tailored searches. Bioinformatics. 2002;18(2):333-334.
24. Bivona TG, Perez De Castro I, Ahearn IM, et al. Phospholipase Cgamma activates Ras on the Golgi apparatus by means of RasGRP1. Nature. 2003;424(6949):694-698.
25. Quatela SE, Philips MR. Ras signaling on the Golgi. Curr Opin Cell Biol. 2006;18(2):162-167.
26. Philips MR. Sef: A MEK/ERK catcher on the Golgi. Mol Cell. 2004;15(2):168-169.
27. Li Q, Yu YY, Zhu ZG, et al. Effect of NF-kappaB constitutive activation on proliferation and apoptosis of gastric cancer cell lines. Eur Surg Res. 2005;37(2):105-110.
28. Rau TT, Rogler A, Frischauf M, et al. Methylation-dependent activation of CDX1 through NF-kappaB: A link from inflammation to intestinal metaplasia in the human stomach. Am J Pathol. 2012;181(2):487-498.
29. Merchant JL. Inflammation, atrophy, gastric cancer: connecting the molecular dots. Gastroenterology. 2005;129(3):1079-1082.
30. Roberts PJ, Der CJ. Targeting the Raf-MEK-ERK mitogen-Activated protein kinase cascade for the treatment of cancer. Oncogene. 2007;26(22):3291-3310.
31. Gysin S, Salt M, Young A, et al. Therapeutic strategies for targeting ras proteins. Genes Cancer. 2011;2(3):359-372.